NFKB1 and Ageusia: Conversely, the observed anti-inflammatory effect and the improvement in ageusia following β-Caryophyllene treatment could be attributed to the inhibition of the NF-κB pathway through activation of its canonical receptor, CB2, as well as to the enhancement of ACE2 enzymatic activity.